Air purifiers cut indoor particles by more than half. The asthma benefit did not follow

A portable HEPA air cleaner will measurably clean the air in a room. Whether that improves allergic disease is a separate question, and the largest placebo-controlled trial to ask it found the answer was no. AIRWEIGHS randomised 164 children with asthma to portable air cleaners with high-efficiency particulate air filters or to identical-looking devices with no filter inside, and reported reductions of 64.0% in ultrafine particles, 64.4% in PM2.5, 54.7% in PM10 and 11.7% in nitrogen dioxide, each significant at P<.05 — alongside no improvement in the primary or secondary asthma outcomes [s1].

The gap between those two results is the whole subject.

What AIRWEIGHS measured

The trial enrolled children aged 10.9 ± 2.5 years, 41% female, 85% Black and 59% overweight or obese, and was designed to test whether overweight and obese children with asthma benefit more from cleaner indoor air than normal-weight children do [s1]. Asthma outcomes and home air pollution were measured at baseline and again 12 weeks after the intervention [s1].

The primary outcome was maximum symptom days over two weeks — the largest value among days of slowed activity, nights of waking, and days of coughing, wheezing or chest tightness due to asthma [s1]. Secondary outcomes included asthma questionnaires, lung function, fractional exhaled nitric oxide and exacerbations [s1].

Baseline pollutant concentrations did not differ between groups: ultrafine particles 45.3 µm²/m³, PM2.5 24.0 µg/m³, PM10 33.0 µg/m³ and NO2 16.7 ppb [s1]. The intervention worked as an air-cleaning device. It did not work as a treatment: there was no improvement in primary or secondary outcomes, and no difference between the normal-weight and overweight groups [s1]. The authors' conclusion is one sentence long — air cleaners effectively reduced indoor air pollution, but there was no observable benefit in asthma outcomes in children [s1].

The sham-device design is what gives this weight. Both groups received a machine that looked and sounded the same, so the comparison isolates the filtration rather than the experience of having a purifier running.

The trial that found something, and where

A double-blind, placebo-controlled crossover trial took a different population: 43 children with asthma living in homes exposed to traffic-related airborne particles [s2]. Each home received a HEPA air cleaner or a dummy unit for four weeks, then a one-month washout, then the other treatment for four weeks [s2]. Indoor concentrations of traffic particles fell significantly with HEPA and not with the dummy [s2].

The clinical result was conditional. In participants who had poorly controlled asthma and lower quality of life at baseline, asthma control questionnaire scores improved from 1.3 to 0.9 (P=0.003) and quality-of-life scores from 4.9 to 5.5 (P=0.02) after the HEPA period [s2].

Forty-three children is a small trial, and a finding located inside a baseline-defined subgroup is the kind of result that most often fails to replicate. But the direction it points is coherent: an intervention that removes a specific exposure might be expected to help the people whose disease is being driven by that exposure, and to do nothing for everyone else. AIRWEIGHS enrolled children with asthma generally, not children whose asthma was demonstrably particle-driven [s1].

The older literature on removing allergens from a home

Air filtration is one branch of a larger idea — that reducing indoor allergen exposure improves allergic disease — and the longest-standing test of that idea concerns house dust mites. A Cochrane review included 54 trials with 3,002 patients with mite-sensitive asthma: 36 assessing physical methods, 26 of them mattress encasings, 10 chemical methods, and 8 combinations [s3].

It found nothing. For the most frequently reported outcome, morning peak flow in 1,565 patients, the standardised mean difference was 0.00 (95% CI -0.10 to 0.10) [s3]. There were no statistically significant differences in the number of patients improved (relative risk 1.01, 0.80 to 1.27), asthma symptom scores (SMD -0.04, -0.15 to 0.07) or medication use (SMD -0.06, -0.18 to 0.07) [s3]. The reviewers note that many trials were of poor quality and would be expected to exaggerate rather than understate an effect — and there was still no effect [s3]. Their conclusion was that chemical and physical methods aimed at reducing house dust mite allergen exposure cannot be recommended [s3].

Two caveats belong with that. The review carries an editorial note stating that it predates current Cochrane reporting standards and methodological expectations and should not be used for clinical decision-making [s3]. And mattress encasing is a different intervention from air filtration — mite allergen travels on heavy particles that settle quickly, which is precisely the fraction an air cleaner is least suited to capturing.

What a buyer is actually buying

The evidence supports a narrow claim confidently: a HEPA unit reduces airborne particle concentrations in a room, by 64.4% for PM2.5 and 54.7% for PM10 in a randomised comparison against a sham device [s1]. It does not support the claim that this improves asthma in children generally [s1]. It offers weak, subgroup-level support for benefit in children whose asthma is poorly controlled and whose homes carry high traffic-particle loads [s2]. And the broader indoor-allergen-avoidance literature it belongs to has a long record of null findings [s3].

None of these trials tested allergic rhinitis, or adults, or pollen, or pet allergen as a primary outcome, so the popular uses of these devices are largely outside the evidence base entirely.

This article describes trial results and is not advice about managing asthma, which is a prescribed treatment decision.

Sources

• AIRWEIGHS: A Randomized Controlled Trial of Air Cleaners in Normal Weight and Overweight/Obese Children With Asthma — Journal of Allergy and Clinical Immunology In Practice, 2025-07-04
• HEPA filtration improves asthma control in children exposed to traffic-related airborne particles — Indoor Air, 2019-11-19
• House dust mite control measures for asthma — Cochrane Database of Systematic Reviews, 2008-04-21